MedPath

Measles-Rebella vaccination study.

Not Applicable
Conditions
eed for immunization against measles alone & Need for immunization against rubella alone.
Need for immunization against measles alone & Need for immunization against rubella alone
Z24.4 & Z2
Registration Number
IRCT2016032827144N1
Lead Sponsor
Centre for Communicable Diseases Control, Ministry of Health and Medical Education
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

all children in the mentioned age rang.
Exclusion criteria: positive history of inoculation of any kind of measles containing vaccine; being a temporary resident for the next 3 months in the region.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Appearence of anit-measles antibodies 8 weeks after vaccination. Timepoint: 8 weeks after vaccination. Method of measurement: measurment of antibody response using ELISA.
Secondary Outcome Measures
NameTimeMethod
Appearence of anti-rubella antibodies. Timepoint: 8 weeks after vaccination. Method of measurement: ELISA.
© Copyright 2025. All Rights Reserved by MedPath